We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Atomoxetine for the Treatment of Cannabis Dependence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00167297
Recruitment Status : Completed
First Posted : September 14, 2005
Last Update Posted : January 11, 2017
University of Pennsylvania
Information provided by:
National Institute on Drug Abuse (NIDA)